Tipranks Press Release.
Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.
Quantum-Si shares are surging. The company said its Proteus protein sequencer can now pick out 19 of the 20 amino acids.
Gainers Quantum-Si (NASDAQ:QSI) stock rose 30.3% to $1.59 during Friday's regular session. The company's market cap stands at $267.0 million. Nautilus Biotechnology (NASDAQ:NAUT) stock rose 26.09% to $2.29.
Three healthcare stocks—Quantum-Si, Kodiak Sciences and Iovance—show overbought RSI readings above 80, warning momentum-focused investors.
U.S. stock futures fell as HubSpot dropped after a downgrade; Roze AI, UMC, Quantum-Si, Intel and others also declined premarket.
Quantum-Si (QSI) stock jumped over 24% after presenting impressive interim Proteus platform data at the HUPO 2026 conference.
All measurable sequencing metrics show profound improvement over Platinum ProBRANFORD, Conn., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced interim development results comparing its next-generation Proteus™ platform with its commercially available Platinum® Pro instrument. Using a developmental sequencing kit that detects
Detailed price information for Quantum-Si Inc (QSI-Q) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.